SILVERARC CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | MLTX | 30K | $215.10K |
 | MBX | 15K | $262.50K |
 | ELVN | 11K | $218.52K |
 | ARCT | 3K | $63.49K |
 | NKTR | 365 | $20.77K |
MoonLake Immunotherapeutics
MLTX
Shares Held
30K
Value
$215.10K
MBX Biosciences, Inc. Common Stock
MBX
Shares Held
15K
Value
$262.50K
Enliven Therapeutics, Inc.
ELVN
Shares Held
11K
Value
$218.52K
Arcturus Therapeutics Holdings Inc.
ARCT
Shares Held
3K
Value
$63.49K
Nektar Therapeutics
NKTR
Shares Held
365
Value
$20.77K